Brain Energy Metabolism in Individuals With Major Depressive Disorder Receiving Escitalopram
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00183677 |
Recruitment Status :
Completed
First Posted : September 16, 2005
Results First Posted : January 4, 2017
Last Update Posted : January 4, 2017
|
Sponsor:
Massachusetts General Hospital
Information provided by (Responsible Party):
David Mischoulon, MD, Massachusetts General Hospital
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Study Type | Interventional |
---|---|
Study Design | Allocation: N/A; Intervention Model: Single Group Assignment; Masking: None (Open Label); Primary Purpose: Treatment |
Condition |
Depression |
Intervention |
Drug: Escitalopram |
Enrollment | 97 |
Participant Flow
Recruitment Details | |
Pre-assignment Details |
Arm/Group Title | Open Label Escitalopram |
---|---|
![]() |
Participants will receive treatment with escitalopram. |
Period Title: Overall Study | |
Started | 97 |
Completed | 53 |
Not Completed | 44 |
Baseline Characteristics
Arm/Group Title | Open Label Escitalopram | |
---|---|---|
![]() |
Participants will receive treatment with escitalopram. | |
Overall Number of Baseline Participants | 97 | |
![]() |
[Not Specified]
|
|
Age, Categorical
Measure Type: Count of Participants Unit of measure: Participants |
||
Number Analyzed | 97 participants | |
<=18 years |
0 0.0%
|
|
Between 18 and 65 years |
97 100.0%
|
|
>=65 years |
0 0.0%
|
|
Age, Continuous
Mean (Standard Deviation) Unit of measure: Years |
||
Number Analyzed | 97 participants | |
41.54 (13.42) | ||
Gender
Measure Type: Count of Participants Unit of measure: Participants |
||
Number Analyzed | 97 participants | |
Female |
42 43.3%
|
|
Male |
55 56.7%
|
|
Region of Enrollment
Measure Type: Number Unit of measure: Participants |
||
United States | Number Analyzed | 97 participants |
97 |
Outcome Measures
Adverse Events
Limitations and Caveats
[Not Specified]
More Information
Results Point of Contact
Name/Title: | Dan Iosifescu, MD, MSc |
Organization: | Massachusetts General Hospital |
EMail: | diosifescu@partners.org |
Responsible Party: | David Mischoulon, MD, Massachusetts General Hospital |
ClinicalTrials.gov Identifier: | NCT00183677 |
Other Study ID Numbers: |
K23MH067111 ( U.S. NIH Grant/Contract ) |
First Submitted: | September 13, 2005 |
First Posted: | September 16, 2005 |
Results First Submitted: | September 22, 2011 |
Results First Posted: | January 4, 2017 |
Last Update Posted: | January 4, 2017 |